Bandaríkin - enska - NLM (National Library of Medicine)

zydus lifesciences limited - eletriptan hydrobromide (unii: m41w832ta3) (eletriptan - unii:22qoo9b8ki) - eletriptan 20 mg - eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use: - use only if a clear diagnosis of migraine has been established. if a patient has no response to the first migraine attack treated with eletriptan hydrobromide, reconsider the diagnosis of migraine before eletriptan hydrobromideis administered to treat any subsequent attacks. - eletriptan hydrobromidetablets arenot intended for the prevention of migraine attacks. - safety and effectiveness of eletriptan hydrobromidehave not been established for cluster headache. eletriptan hydrobromide is contraindicated in patients with: - ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal's angina [see warnings and precautions (5.1)]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorde

Bandaríkin - enska - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - eletriptan hydrobromide (unii: m41w832ta3) (eletriptan - unii:22qoo9b8ki) - eletriptan 20 mg - eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use: - use only if a clear diagnosis of migraine has been established. if a patient has no response to the first migraine attack treated with eletriptan hydrobromide, reconsider the diagnosis of migraine before eletriptan hydrobromideis administered to treat any subsequent attacks. - eletriptan hydrobromidetablets arenot intended for the prevention of migraine attacks. - safety and effectiveness of eletriptan hydrobromidehave not been established for cluster headache. eletriptan hydrobromide is contraindicated in patients with: - ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal's angina [see warnings and precautions (5.1)]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorde

Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline pharmaceuticals sa-nv - sumatriptan succinate 70 mg - eq. sumatriptan 100 mg - dispersible tablet - 50 mg - sumatriptan succinate 70 mg - sumatriptan

Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline pharmaceuticals sa-nv - sumatriptan succinate 140 mg - eq. sumatriptan 100 mg - dispersible tablet - 100 mg - sumatriptan succinate 140 mg - sumatriptan

Jórdanía - enska - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الأدوية الأردني - the jordan drugstore co - hydrochlorothiazide 25 mg - 25 mg

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - dihydralazine, hydrochlorthiazide, reserpine - tablet - 0.1, 10, 10 mg

Kanada - enska - Health Canada

mylan pharmaceuticals ulc - sumatriptan (sumatriptan succinate) - tablet - 25mg - sumatriptan (sumatriptan succinate) 25mg - selective serotonin agonists

Kanada - enska - Health Canada

mylan pharmaceuticals ulc - sumatriptan (sumatriptan succinate) - tablet - 50mg - sumatriptan (sumatriptan succinate) 50mg - selective serotonin agonists

Kanada - enska - Health Canada

mylan pharmaceuticals ulc - sumatriptan (sumatriptan succinate) - tablet - 100mg - sumatriptan (sumatriptan succinate) 100mg - selective serotonin agonists